Evidence map›Paper›PMID 25883756›Full record

ArticleJournal of cardiovascular ultrasound2015

Cardiac involvement of churg-strauss syndrome as a reversible cause of dilated cardiomyopathy.

Hae Chang Jeong, Kye Hun Kim, Jae Yeong Cho, Ji Eun Song, Hyun Ju Yoon, Hyun Ju Seon, Youngkeun Ahn, Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of cardiovascular ultrasound, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Angina in granulomatosis with polyangiitis: A case report.Experimental and therapeutic medicine · 2017
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hae Chang JeongDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Kye Hun KimDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Jae Yeong ChoDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Ji Eun SongDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Hyun Ju YoonDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Hyun Ju SeonDepartment of Radiology, Chonnam National University Hospital, Gwangju, Korea.
Youngkeun AhnDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Myung Ho JeongDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Jeong Gwan ChoDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Jong Chun ParkDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Chonnam National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 31-year-old male who had been treated for Churg-Strauss syndrome (CSS) presented with sudden onset of dysarthria. Brain magnetic resonance imaging (MRI) showed acute multifocal bilateral cerebral infarctions suggesting embolic causes. Cardiac MRI showed dilated cardiomyopathy with severe biventricular dysfunction with intracardiac thrombi, and multiple high signal intensity spots in myocardium of the left ventricle with multifocal delayed enhancement suggesting multifocal myocarditis due to small vessel vasculitis associated with CSS. After anticoagulation therapy, treatments for heart failure, and immunosuppressive therapy including parenteral steroids and cyclophosphamide to control CSS, the symptoms and signs of heart failure and cardiac function of the patient were improved. Considering the pathophysiologic mechanism of cardiac involvement in CSS, immunosuppressive therapy to control the disease activity of CSS should be taken into account, besides usual management for heart failure.

Indexed as

Churg-Strauss syndromeDilated cardiomyopathyPrognosis

Identifiers

PMID25883756
PMCPMC4398784
OpenAlexW2092459907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.